These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 29493116)

  • 61. Changes in IGFBP-2 levels following a one-year lifestyle modification program are independently related to improvements in plasma apo B and LDL apo B levels.
    Carter S; Lemieux I; Li Z; Alméras N; Tremblay A; Bergeron J; Poirier P; Després JP; Picard F
    Atherosclerosis; 2019 Feb; 281():89-97. PubMed ID: 30658196
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Circulating IGFBP-2 levels are inversely associated with the incidence of nonalcoholic fatty liver disease: A cohort study.
    Yang J; Zhou W; Wu Y; Xu L; Wang Y; Xu Z; Yang Y
    J Int Med Res; 2020 Aug; 48(8):300060520935219. PubMed ID: 32762395
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Early pregnancy serum IGFBP-1 relates to lipid profile in overweight and obese women.
    Mokkala K; Juhila J; Houttu N; Sorsa T; Laitinen K
    Heliyon; 2020 Aug; 6(8):e04788. PubMed ID: 32923723
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Insulin-Like Growth Factor Binding Protein 2 (IGFBP-2) and the Risk of Developing Type 2 Diabetes.
    Wittenbecher C; Ouni M; Kuxhaus O; Jähnert M; Gottmann P; Teichmann A; Meidtner K; Kriebel J; Grallert H; Pischon T; Boeing H; Schulze MB; Schürmann A
    Diabetes; 2019 Jan; 68(1):188-197. PubMed ID: 30396904
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Are spexin levels associated with metabolic syndrome, dietary intakes and body composition in children?
    Behrooz M; Vaghef-Mehrabany E; Moludi J; Ostadrahimi A
    Diabetes Res Clin Pract; 2021 Feb; 172():108634. PubMed ID: 33347897
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Serum Fibroblast Growth Factor 1 is Associated with the Decreased Risk of Obesity in Human.
    Zhu J; Wang Y; Zhu K; Gao J; Wan X; Pang X; Fei S
    Exp Clin Endocrinol Diabetes; 2017 May; 125(5):322-326. PubMed ID: 28303556
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The relationship between IGF-2, IGFBP-2, and IGFBP-3 levels in patients suffering from pre-diabetes.
    Ismayilnajadteymurabadi H; Konukoglu D
    J Biol Regul Homeost Agents; 2018; 32(1):63-68. PubMed ID: 29504366
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Adipokines in glucose and lipid metabolism.
    Wang X; Zhang S; Li Z
    Adipocyte; 2023 Dec; 12(1):2202976. PubMed ID: 37077042
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Obesity: a perfect storm for carcinogenesis.
    Harris BHL; Macaulay VM; Harris DA; Klenerman P; Karpe F; Lord SR; Harris AL; Buffa FM
    Cancer Metastasis Rev; 2022 Sep; 41(3):491-515. PubMed ID: 36038791
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Associations between insulin-like growth factor binding protein-2 and lipoprotein kinetics in men.
    Rauzier C; Lamarche B; Tremblay AJ; Couture P; Picard F
    J Lipid Res; 2022 Oct; 63(10):100269. PubMed ID: 36030928
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cardiovascular Biomarker Profiles in Obesity and Relation to Normalization of Subclinical Cardiac Dysfunction after Bariatric Surgery.
    Snelder SM; Pouw N; Aga Y; Castro Cabezas M; Biter LU; Zijlstra F; Kardys I; van Dalen BM
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159232
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The Insight into Insulin-Like Growth Factors and Insulin-Like Growth-Factor-Binding Proteins and Metabolic Profile in Pediatric Obesity.
    Czogała W; Strojny W; Tomasik P; Multanowski MB; Wójcik M; Miklusiak K; Krzysztofik E; Wróbel A; Miklusiak K; Skoczeń S
    Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371941
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Early-Life Metabolic and Hormonal Markers in Blood and Growth until Age 2 Years: Results from a Randomized Controlled Trial in Healthy Infants Fed a Modified Low-Protein Infant Formula.
    Kouwenhoven SMP; Fleddermann M; Finken MJJ; Twisk JWR; van der Beek EM; Abrahamse-Berkeveld M; van de Heijning BJM; van Harskamp D; van Goudoever JB; Koletzko BV
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33915788
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Potential Role of Insulin Growth-Factor-Binding Protein 2 as Therapeutic Target for Obesity-Related Insulin Resistance.
    Boughanem H; Yubero-Serrano EM; López-Miranda J; Tinahones FJ; Macias-Gonzalez M
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498859
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of Long-Term HFD Intake on the Peripheral and Central IGF System in Male and Female Mice.
    Guerra-Cantera S; Frago LM; Jiménez-Hernaiz M; Ros P; Freire-Regatillo A; Barrios V; Argente J; Chowen JA
    Metabolites; 2020 Nov; 10(11):. PubMed ID: 33202914
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of gastric sleeve surgery on the serum levels of GH, IGF-1 and IGF-binding protein 2 in healthy obese patients.
    Al-Regaiey K; Alshubrami S; Al-Beeshi I; Alnasser T; Alwabel A; Al-Beladi H; Al-Tujjar O; Alnasser A; Alfadda AA; Iqbal M
    BMC Gastroenterol; 2020 Jun; 20(1):199. PubMed ID: 32586279
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Transcriptional Analysis of FOXO1, C/EBP-α and PPAR-γ2 Genes and Their Association with Obesity-Related Insulin Resistance.
    Boughanem H; Cabrera-Mulero A; Millán-Gómez M; Garrido-Sánchez L; Cardona F; Tinahones FJ; Moreno-Santos I; Macías-González M
    Genes (Basel); 2019 Sep; 10(9):. PubMed ID: 31547433
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Proteins Altered by Surgical Weight Loss Highlight Biomarkers of Insulin Resistance in the Community.
    Shah RV; Hwang SJ; Yeri A; Tanriverdi K; Pico AR; Yao C; Murthy V; Ho J; Vitseva O; Demarco D; Shah S; Iafrati MD; Levy D; Freedman JE
    Arterioscler Thromb Vasc Biol; 2019 Jan; 39(1):107-115. PubMed ID: 30580566
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The insulin like growth factor and binding protein family: Novel therapeutic targets in obesity & diabetes.
    Haywood NJ; Slater TA; Matthews CJ; Wheatcroft SB
    Mol Metab; 2019 Jan; 19():86-96. PubMed ID: 30392760
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.